Brief: Genscript Biotech Says Unit Receives $213.8 Million Under R+A Agreement
30/06/2025 02:30
June 30 (Reuters) - Genscript Biotech Corp 1548.HK: UNIT RECEIVES $213.8 MILLION UNDER R+A AGREEMENT Further company coverage: 1548.HK ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Genscript Biotech
See all newsBrief: Genscript Launches Life Sciences Startup Pitchfest With Nvidia For Biotech Innovation
GenScript Biotech extends gain to hit near 5-year peak on Eli Lilly deal
GenScript Biotech hits near 5-year high on Eli Lilly collaboration
Brief: ProBio & Kun Tuo Announce Strategic Collaboration To Deliver Integrated CDMO-CRO Solutions
HK-listed GenScript Biotech drops on discounted share sale